| Condition | Key Finding | Association | Board Exam Tip |
| Paget's Disease of the Nipple | Scaly/Exudative changes on nipples | Underlying breast carcinoma (usually DCIS) | Always suspect underlying malignancy when skin changes are noted; requires biopsy. |
| PCOS Hyperandrogenism | Elevated testosterone, hirsutism | Increased 5-reductase activity in skin | Treat with Spironolactone to inhibit the conversion of T to DHT. |
| Molar Pregnancy | Uterus size > BPD (early gestation) | High -hCG; "Snowstorm" ultrasound appearance | Requires suction curettage; risk of developing choriocarcinoma. |
| Chlamydia trachomatis | Watery/non-gonococcal urethritis | Cannot be visualized on Gram stain | Diagnosis requires Nucleic Acid Amplification Testing (NAAT). |
| Topic | Key Point | Context | Exam Relevance |
| PCOS | Hyperandrogenism treatment | Spironolactone inhibits 5-reductase in the skin. | High-yield pharmacology concept; remember it's an anti-androgen, not just a hormone regulator. |
| Endometrial Cancer Risk | Screening necessity | PCOS or long-term HRT use mandates screening for endometrial cancer regardless of age (<50). | Common trap question: Do not wait for symptoms if risk factors are present. |
| Molar Pregnancy | Diagnostic triad | Large uterus, high -hCG, snowstorm ultrasound. | Distinguishes it from normal intrauterine pregnancy and guides immediate management (suction curettage). |
| BPH Acute Management | Alpha-1 Blockers | Tamsulosin is preferred over older agents because its action is localized to the bladder neck, minimizing systemic hypotension risk. | Focus on targeted drug choice for acute symptom relief vs. long-term shrinkage. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A woman with a history of PCOS and heavy menstrual bleeding is found to have an endometrial biopsy showing atypical hyperplasia. | Endometrial Carcinoma (Risk) | Hyperestrogenism from unopposed estrogen exposure (PCOS, HRT) increases the risk of endometrial cancer, necessitating screening regardless of age. |
| A 57-year-old woman on long-term estrogen replacement therapy develops unexplained weight loss and vaginal bleeding. | Endometrial Carcinoma | Estrogen use in postmenopausal women is a major risk factor for unopposed estrogen exposure leading to endometrial hyperplasia/cancer. |
| A patient with chronic angina who takes both a nitrate vasodilator and a phosphodiesterase inhibitor presents with acute erectile dysfunction. | Drug Interaction: Nitrates + PDE-5i | Both drug classes cause profound vasodilation, leading to severe hypotension and impaired erection (priapism risk). Never combine these drugs. |
| A young woman presents with watery urethral discharge and negative Gram stain culture results. | Chlamydia trachomatis STI | This presentation is classic for Non-Gonococcal Urethritis (NGU); C. trachomatis cannot be visualized on a standard Gram stain, requiring NAAT testing. |
| A 60-year-old man with chronic urinary dribbling and urgency has been diagnosed with BPH. | _1-blocker therapy / Tamsulosin | Acute symptom relief is achieved by blocking the _1 receptor in the bladder neck (Tamsulosin), avoiding systemic hypotension risks associated with general vasodilators. |
| A biopsy of a breast mass reveals central clearing and an e-cat hearing mutation, along with high suspicion for malignancy. | Invasive Lobulocarcinoma | This specific molecular finding is highly correlated with this aggressive subtype; treatment requires anti-HER2 therapy (Trastuzumab). |
| Key Features | Distinguishing Findings | Next Step |
| Neisseria gonorrhoeae | Mucopurulent discharge; high prevalence in pharyngeal/urethral sites. | Treat empirically with Ceftriaxone (and often Azithromycin). |
| Chlamydia trachomatis | Watery, non-gonococcal urethritis; negative Gram stain. | Test via NAAT (Nucleic Acid Amplification Testing); treat with Doxycycline/Azithromycin. |
| Key Features | Distinguishing Findings | Next Step |
| Fibroadenoma | Single, mobile, rubbery mass; cyclical pain common in young women. | Observation (usually); biopsy only if suspicious features are present. |
| Paget's Disease of the Nipple | Scaly, erythematous, or crusting changes on nipples/areola. | Treat underlying malignancy; requires full-thickness skin biopsy to confirm Paget's pattern. |
| Condition | Association | Mechanism | Clinical Significance |
| PCOS | Hirsutism/Acne | Increased activity of 5-reductase in the skin. | Use Spironolactone to inhibit this enzyme and reduce androgen effects. |
| Molar Pregnancy | Choriocarcinoma risk | Trophoblastic tissue contains pluripotent cells capable of malignant transformation. | Requires aggressive monitoring and potential Methotrexate treatment post-curettage. |
| BPH | Acute symptoms relief | _1 receptors are concentrated in the bladder neck/prostate smooth muscle. | Targeted blockers (Tamsulosin) provide symptom relief with fewer systemic side effects than general vasodilators. |
| Breast Cancer | Invasive Lobulocarcinoma | Associated with e-cat hearing mutations. | Requires anti-HER2 therapy (Trastuzumab); monitor cardiac function pre-treatment. |
| Term | Definition | Context | Example |
| Spironolactone | Potassium-sparing diuretic; Anti-androgen. | Treating hyperandrogenism in PCOS. | Used to treat hirsutism by inhibiting 5-reductase activity. |
| Tamsulosin | Selective _1 receptor antagonist. | Acute management of Benign Prostatic Hyperplasia (BPH). | Blocks receptors in the bladder neck, providing rapid symptom relief without profound systemic hypotension. |
| -fetoprotein (-AFP) | Tumor marker protein; elevated in yolk sac tumors. | Ovarian/Testicular germ cell tumor diagnosis. | Elevated -AFP strongly suggests a Yolk Sac Tumor over other ovarian masses. |
| Snowstorm Appearance | Ultrasound finding of heterogeneous, highly echogenic material within the uterus. | Diagnosis of Molar Pregnancy. | Indicates abnormal placental tissue and requires immediate suction curettage. |
| Topic | Study Approach | Priority | Resources |
| Gynecologic Oncology | Focus on risk factors/screening guidelines. | High (Board-level traps) | Review PCOS, HRT, and Molar Pregnancy protocols; memorize the differential markers (-AFP vs -hCG). |
| Endocrine Pharmacology | Drug mechanism and side effects. | Medium-High | Master anti-androgens (Spironolactone), _1 blockers (Tamsulosin), and vasodilation risks (Nitrates/PDE-5i). |
| Infectious Disease | Gram stain limitations and NAAT necessity. | High (Step 1/2) | Know the difference between N. gonorrhoeae (mucopurulent, stains well) and C. trachomatis (watery, cannot stain). |
🚫Mistake: Thinking all breast masses are benign if mobile. Correction: While fibroadenomas are common, any hard mass or suspicious change (e.g., Paget's changes) requires thorough evaluation and biopsy to rule out malignancy.